
The BreatheAmerica model represents a transformation from the traditional physician specialty model into a patient and disease centric model. The major components of the company's model grew out of work done in one of the country's leading academic medical centers that innovated and incubated a comprehensive multi-disciplinary program focused on the treatment of airway disease. BreatheAmerica's integrated model is organized to:

Approximately 34.1 million Americans have been diagnosed with asthma during their lifetime.
About 70% of asthmatics also have allergies.
It is estimated that the number of people with asthma will grow by more than 100 million by 2025.
The annual economic cost of asthma is $19.7 billion. Direct costs make up $14.7 billion of that total, and indirect costs such as lost productivity add another $5 billion.